Abbott Optium Omega
The technology used in the Abbott Optium Omega, to measure blood glucose, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||★ Recommendation||Recent clinical validation; older protocol|
Solnica B, Kusnierz-Cabala B, Slowinska-Solnica K, Witek P, Cempa A, Malecki MT. Evaluation of the analytical performance of the coulometry-based Optium Omega blood glucose meter. J Diabetes Sci Technol. 2011 Nov 1;5(6):1612-7. PMID: 22226286.
15197:2003 - Pass General population
ADA:1987 - Pass General population
Krouwer JS. Evaluation of the analytical performance of the coulometry-based Optium Omega blood glucose meter: what do such evaluations show? J Diabetes Sci Technol. 2011 Nov 1;5(6):1618-20. PMID: 22226287.
The publication is a letter or correspondence in which the Abbott Optium Omega is referenced.